162 related articles for article (PubMed ID: 29633932)
1. Tacrolimus-Induced Autoimmune Hemolytic Anemia in a Previously Reported Child With History of Thrombocytopenia Following Liver Transplant.
Kaya Z; Egritas O; Dalgic B
Exp Clin Transplant; 2018 Jun; 16(3):355-356. PubMed ID: 29633932
[No Abstract] [Full Text] [Related]
2. Autoimmune hemolytic anemia in solid organ transplantation-The role of immunosuppression.
Kanellopoulou T
Clin Transplant; 2017 Sep; 31(9):. PubMed ID: 28621877
[TBL] [Abstract][Full Text] [Related]
3. Understanding and Preventing Adverse Effects of Tacrolimus Metabolization in Transplant Patients.
Fröhlich E
Curr Drug Metab; 2019; 20(13):1039-1040. PubMed ID: 30081785
[No Abstract] [Full Text] [Related]
4. Tacrolimus-related posttransplant lymphoproliferative disorder presenting as autoimmune hemolytic anemia.
DiGiuseppe JA; Bastacky SI; Shirey RS; Silberman MA; Hutchins GM; Ness PM
Arch Pathol Lab Med; 1996 Mar; 120(3):282-5. PubMed ID: 8629906
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus-Induced Diabetic Ketoacidosis After Allogeneic Bone Marrow Transplant.
Solmaz S; Gökgöz Z; Gereklioğlu Ç; Yeral M; Boğa C; Özdoğu H
Exp Clin Transplant; 2017 Dec; 15(6):702-703. PubMed ID: 26643544
[TBL] [Abstract][Full Text] [Related]
6. Treatment and outcomes of immune cytopenias following solid organ transplant in children.
Schoettler M; Elisofon SA; Kim HB; Blume ED; Rodig N; Boyer D; Neufeld EJ; Grace RF
Pediatr Blood Cancer; 2015 Feb; 62(2):214-218. PubMed ID: 25308853
[TBL] [Abstract][Full Text] [Related]
7. Adequate exposure to tacrolimus with sublingual administration in pediatric liver transplant patients.
Riva N; Galván ME; Cáceres-Guido P; Dip M; Licciardone N; Imventarza O; Schaiquevich P; Buamscha D
Int J Clin Pharmacol Ther; 2017 Apr; 55(4):352-354. PubMed ID: 28079516
[No Abstract] [Full Text] [Related]
8. Conversion From Once-Daily Prolonged-Release Tacrolimus to Once-Daily Extended-Release Tacrolimus in Stable Liver Transplant Recipients.
Altieri M; Delaval G; Kimmoun E; Allaire M; Salamé E; Dumortier J
Exp Clin Transplant; 2018 Jun; 16(3):321-325. PubMed ID: 28697715
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of Evans syndrome with Tacrolimus.
Tabchi S; Hanna C; Kourie HR; Aftimos P; El Osta L; Ghosn M
Invest New Drugs; 2015 Feb; 33(1):254-6. PubMed ID: 25209619
[No Abstract] [Full Text] [Related]
10. Successful treatment of tacrolimus-related pure red cell aplasia and autoimmune hemolytic anemia with rituximab in a pediatric cardiac transplant patient.
Abongwa C; Abusin G; El-Sheikh A
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28598573
[TBL] [Abstract][Full Text] [Related]
11. A Pilot Study of the Pharmacokinetics of the Modified-Release Once-Daily Tacrolimus Formulation Administered to Living-Donor Liver Transplant Recipients.
Song GW; Lee SG; Hwang S; Kim KH; Kim WJ; Sin MH; Yoon YI; Tak EY
Exp Clin Transplant; 2016 Aug; 14(4):412-8. PubMed ID: 26976646
[TBL] [Abstract][Full Text] [Related]
12. Twice-Weekly Tacrolimus Can Overcome Pharmacologic Interaction and Help in the Successful Treatment of Pulmonary Aspergillosis in a Liver Transplant Recipient.
Chiu YC; Ho MH; Chen TW; Hsieh CB; Fan HL
Exp Clin Transplant; 2019 Dec; 17(6):838-840. PubMed ID: 30373507
[TBL] [Abstract][Full Text] [Related]
13. Evan's syndrome precipitated by fludarabine therapy in a case of CLL.
Sen K; Kalaycio M
Am J Hematol; 1999 Jul; 61(3):219. PubMed ID: 10398320
[No Abstract] [Full Text] [Related]
14. Targeting High Calcineurin Inhibitor Levels After Acute Rejection With Less Tremor: A New Strategy.
Alhamad T; Venkatachalam K; Daloul R; Brennan DC; Malone AF
Transplantation; 2017 Aug; 101(8):e287-e288. PubMed ID: 28422926
[No Abstract] [Full Text] [Related]
15. Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children.
Basu B; Babu BG; Mahapatra TK
Clin Exp Nephrol; 2017 Feb; 21(1):143-151. PubMed ID: 27108294
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroid-Sparing and Optimization of Mycophenolic Acid Exposure in Liver Transplant Recipients Receiving Mycophenolate Mofetil and Tacrolimus: A Randomized, Multicenter Study.
Saliba F; Rostaing L; Gugenheim J; Durand F; Radenne S; Leroy V; Neau-Cransac M; Calmus Y; Salamé E; Pageaux GP; Duvoux C; Taguieva N; Sinnasse-Raymond G; Sebagh M; Samuel D; Marquet P
Transplantation; 2016 Aug; 100(8):1705-13. PubMed ID: 27454919
[TBL] [Abstract][Full Text] [Related]
17. Cold agglutinin syndrome in pediatric liver transplant recipients.
Wong W; Merker JD; Nguyen C; Berquist W; Jeng M; Viele M; Glader B; Fontaine MJ
Pediatr Transplant; 2007 Dec; 11(8):931-6. PubMed ID: 17976131
[TBL] [Abstract][Full Text] [Related]
18. Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation.
Chapman WC; Brown RS; Chavin KD; Sudan D; Koneru B; Junge G; Dong G; Patel D; Teperman L; Fung JJ
Transplantation; 2017 Feb; 101(2):341-349. PubMed ID: 28121741
[TBL] [Abstract][Full Text] [Related]
19. High-dose mizoribine combined with calcineurin inhibitor (cyclosporine or tacrolimus), basiliximab and corticosteroids for renal transplantation: A Japanese multicenter study.
Nishioka T; Yoshimura N; Ushigome H; Watarai Y; Nishimura K; Akioka K; Nakamura N; Kawakita M; Yuzawa K; Nakatani T
Int J Urol; 2018 Feb; 25(2):141-145. PubMed ID: 29068092
[TBL] [Abstract][Full Text] [Related]
20. First experience with extended release tacrolimus in the treatment of adult patients with severe, difficult to treat atopic dermatitis: Clinical efficacy, safety and dose finding.
van der Schaft J; van Schaik RH; van Zuilen AD; Hijnen DJ; Berg MT; van den Broek MP; Bruijnzeel-Koomen CA; de Bruin-Weller MS
J Dermatol Sci; 2016 Jan; 81(1):66-8. PubMed ID: 26547110
[No Abstract] [Full Text] [Related]
[Next] [New Search]
